Nov. 12, 2025 — Siemens has introduced plans to deconsolidate its remaining stake in Siemens Healthineers (presently circa 67 %). The corporate plans to switch 30 % of Siemens Healthineers shares to Siemens AG shareholders by means of a direct spin-off as preferable possibility. Thus, Siemens shareholders will profit straight and obtain shares in Siemens Healthineers. On the similar time, the deconsolidation will present potential to unlock long-term worth for Siemens shareholders as a extra centered know-how firm with a extremely synergistic Siemens portfolio.
Siemens plans to cut back its stake in Siemens Healthineers to a major minority to permit higher capital allocation flexibility. Thereby, Siemens additionally continues to take part within the engaging enterprise of Siemens Healthineers as a minority shareholder. Within the medium time period it’s focused to cut back the shareholding to a monetary asset. Siemens is dedicated to managing its funding in Siemens Healthineers in a accountable and shareholder-focused method. Furthermore, Siemens reaffirms its dedication to a progressive dividend coverage, which shall be maintained even after the deconsolidation of Siemens Healthineers.
“Right now marks the start of the subsequent stage of progress for Siemens. By giving up the controlling majority in Siemens Healthineers, we’re specializing in a extremely synergistic Siemens portfolio” mentioned Roland Busch, President and Chief Government Officer of Siemens AG. “This can be a logical subsequent step in executing our technique of mixing the actual and the digital worlds, specializing in accelerated worthwhile progress of our digital companies, linked and software program outlined {hardware} and industrial AI.”
“Every of the 2 firms has a robust monetary profile providing strategic flexibility to speed up worth creation of their respective core markets by means of tailor-made capital allocation – enabling each organizations to function with higher agility and focus. For Siemens, the deconsolidation offers further leeway, will increase transparency whereas decreasing complexity for the capital market, and simplifies governance constructions. On the similar time, the best way of spin-off is a market-friendly switch of shares,” mentioned Ralf P. Thomas, Chief Monetary Officer of Siemens AG.
As beforehand introduced, the choice follows a radical evaluation and strategic assessment of how each firms can finest notice their full potential, speed up their respective transformations, and efficiently faucet into new areas of progress. This sharpens Siemens’ profile as ONE Tech Firm, driving stronger buyer focus, sooner innovation, and accelerated worthwhile progress. On the similar time, Siemens Healthineers is benefiting from a considerably increased free float, and subsequently higher attractiveness for the capital market as a number one pure-play MedTech champion.
The supposed transaction is topic to remaining regulatory clarifications and approvals by shareholder conferences of each firms, Siemens and Siemens Healthineers. Within the coming months, Siemens will proceed to work intently with the related events on detailing the construction and timing of the transaction. Additional particulars shall be offered in early Q2, calendar yr 2026.
